$0.76 0.02 (+2.59%)
11/27/2009 12:59 PM

Antigenics, Inc. (AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Featured Broker Partners